Detailed information for compound 1507638

Basic information

Technical information
  • TDR Targets ID: 1507638
  • Name: N-[5-(3-fluoropyridin-4-yl)-6-pyridin-3-ylpyr azin-2-yl]cyclopropanecarboxamide
  • MW: 335.335 | Formula: C18H14FN5O
  • H donors: 1 H acceptors: 5 LogP: 1.03 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(C1CC1)Nc1cnc(c(n1)c1cccnc1)c1ccncc1F
  • InChi: 1S/C18H14FN5O/c19-14-9-21-7-5-13(14)17-16(12-2-1-6-20-8-12)23-15(10-22-17)24-18(25)11-3-4-11/h1-2,5-11H,3-4H2,(H,23,24,25)
  • InChiKey: XUYURJQIMYCWBB-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-[5-(3-fluoro-4-pyridyl)-6-(3-pyridyl)pyrazin-2-yl]cyclopropanecarboxamide
  • N-[5-(3-fluoro-4-pyridyl)-6-(3-pyridyl)-2-pyrazinyl]cyclopropanecarboxamide
  • N-[5-(3-fluoropyridin-4-yl)-6-pyridin-3-yl-pyrazin-2-yl]cyclopropanecarboxamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens cytochrome P450, family 3, subfamily A, polypeptide 4 Starlite/ChEMBL References
Homo sapiens cytochrome P450, family 2, subfamily C, polypeptide 19 Starlite/ChEMBL References
Homo sapiens adenosine A2b receptor Starlite/ChEMBL References
Mus musculus adenosine A2b receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Candida albicans similar to C.maltosa N-alkane inducible cytochrome P-450, ALK8 CYP52A11 Get druggable targets OG5_126554 All targets in OG5_126554
Loa Loa (eye worm) cytochrome P450 family protein Get druggable targets OG5_126554 All targets in OG5_126554
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126554 All targets in OG5_126554
Candida albicans cytochrome P450 556 Get druggable targets OG5_126554 All targets in OG5_126554
Leishmania infantum cytochrome p450-like protein Get druggable targets OG5_126554 All targets in OG5_126554
Brugia malayi Cytochrome P450 family protein Get druggable targets OG5_126582 All targets in OG5_126582
Candida albicans cytochrome P450 56 Get druggable targets OG5_126554 All targets in OG5_126554
Trypanosoma congolense cytochrome P450, putative Get druggable targets OG5_126554 All targets in OG5_126554
Trypanosoma cruzi cytochrome P450, putative Get druggable targets OG5_126554 All targets in OG5_126554
Mycobacterium ulcerans cytochrome P450 185A4 Cyp185A4 Get druggable targets OG5_126554 All targets in OG5_126554
Leishmania braziliensis cytochrome p450-like protein Get druggable targets OG5_126554 All targets in OG5_126554
Leishmania donovani cytochrome p450-like protein Get druggable targets OG5_126554 All targets in OG5_126554
Leishmania major cytochrome p450-like protein Get druggable targets OG5_126554 All targets in OG5_126554
Loa Loa (eye worm) cytochrome P450 family protein Get druggable targets OG5_126554 All targets in OG5_126554
Loa Loa (eye worm) cytochrome P450 family protein Get druggable targets OG5_126582 All targets in OG5_126582
Brugia malayi Cytochrome P450 family protein Get druggable targets OG5_126554 All targets in OG5_126554
Trypanosoma brucei gambiense cytochrome P450, putative Get druggable targets OG5_126554 All targets in OG5_126554
Brugia malayi Cytochrome P450 family protein Get druggable targets OG5_126554 All targets in OG5_126554
Trypanosoma brucei cytochrome P450, putative Get druggable targets OG5_126554 All targets in OG5_126554
Loa Loa (eye worm) CYP4Cod1 Get druggable targets OG5_126554 All targets in OG5_126554
Leishmania mexicana cytochrome p450-like protein Get druggable targets OG5_126554 All targets in OG5_126554
Candida albicans similar to C.maltosa N-alkane inducible cytochrome P-450, ALK8 CYP52A11 Get druggable targets OG5_126554 All targets in OG5_126554
Trypanosoma cruzi cytochrome P450, putative Get druggable targets OG5_126554 All targets in OG5_126554
Candida albicans closely related to C.maltosa N-alkane-inducible cytochrome P-450, alkane hydroxylating monooxygenase CYP52A3-b aka P450Alk1A (BA Get druggable targets OG5_126554 All targets in OG5_126554

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma mansoni dro/myosuppressin receptor adenosine A2b receptor 332 aa 325 aa 22.5 %
Brugia malayi cytochrome P450 cytochrome P450, family 3, subfamily A, polypeptide 4 502 aa 492 aa 24.2 %
Leishmania major cytochrome p450-like protein cytochrome P450, family 2, subfamily C, polypeptide 19 490 aa 411 aa 23.1 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus fibronectin type III domain-containing protein 0.0071 0.1846 0.1846
Echinococcus granulosus nephrin 0.0092 0.3268 0.3268
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Echinococcus multilocularis anosmin 1 0.0071 0.1846 0.1846
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.0071 0.1846 0.1846
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Brugia malayi Twik (KCNK-like) family of potassium channels, alpha subunit 32 0.0071 0.1846 0.2667
Brugia malayi Immunoglobulin I-set domain containing protein 0.0116 0.4923 0.7111
Loa Loa (eye worm) immunoglobulin I-set domain-containing protein 0.0116 0.4923 0.7111
Echinococcus multilocularis anosmin 1 0.0071 0.1846 0.1846
Brugia malayi hypothetical protein 0.0145 0.6923 1
Brugia malayi Immunoglobulin I-set domain containing protein 0.0092 0.3268 0.472
Loa Loa (eye worm) hypothetical protein 0.0145 0.6923 1
Loa Loa (eye worm) immunoglobulin I-set domain-containing protein 0.0092 0.3268 0.472
Echinococcus multilocularis receptor type tyrosine protein phosphatase protein tyrosine phosphatase receptor type 0.0071 0.1846 0.1846
Loa Loa (eye worm) TK/KIN16 protein kinase 0.0118 0.5103 0.7371
Trypanosoma brucei Fibronectin type III domain containing protein, putative 0.0071 0.1846 0.5
Leishmania major hypothetical protein, conserved 0.0071 0.1846 0.5
Echinococcus multilocularis Fibronectin type III domain containing protein 0.0071 0.1846 0.1846
Echinococcus multilocularis Netrin receptor DCC 0.0071 0.1846 0.1846
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.0092 0.3268 0.3268
Echinococcus granulosus Phosphotidylinositol phosphatase PTPRQ 0.0071 0.1846 0.1846
Schistosoma mansoni cell adhesion molecule 0.0168 0.8578 1
Echinococcus multilocularis contactin neuroglian septate junction protein 0.0116 0.4923 0.4923
Loa Loa (eye worm) immunoglobulin I-set domain-containing protein 0.0095 0.3502 0.5058
Trypanosoma cruzi hypothetical protein, conserved 0.0071 0.1846 0.5
Echinococcus granulosus EG95 0.0071 0.1846 0.1846
Echinococcus granulosus twitchin 0.0094 0.3422 0.3422
Loa Loa (eye worm) hypothetical protein 0.0145 0.6923 1
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Echinococcus multilocularis Immunoglobulin 0.0073 0.2 0.2
Brugia malayi Fibronectin type III domain containing protein 0.0071 0.1846 0.2667
Schistosoma mansoni receptor tyrosine phosphatase type r2a 0.0071 0.1846 0.2152
Echinococcus granulosus contactin 0.0116 0.4923 0.4923
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Brugia malayi Immunoglobulin I-set domain containing protein 0.0092 0.3268 0.472
Echinococcus multilocularis receptor type tyrosine protein phosphatase 0.0116 0.4923 0.4923
Echinococcus multilocularis Netrin receptor DCC 0.0071 0.1846 0.1846
Brugia malayi Fibronectin type III domain containing protein 0.0071 0.1846 0.2667
Brugia malayi Lethal protein 805 0.0071 0.1846 0.2667
Echinococcus multilocularis receptor type tyrosine protein phosphatase 0.0116 0.4923 0.4923
Brugia malayi myotactin form B 0.0071 0.1846 0.2667
Echinococcus granulosus titin 0.0092 0.3268 0.3268
Schistosoma mansoni cell adhesion molecule 0.0116 0.4923 0.5739
Brugia malayi Immunoglobulin I-set domain containing protein 0.0092 0.3268 0.472
Loa Loa (eye worm) lethal protein 805 0.0071 0.1846 0.2667
Echinococcus granulosus anosmin 1 0.0071 0.1846 0.1846
Echinococcus multilocularis Phosphotidylinositol phosphatase PTPRQ 0.0071 0.1846 0.1846
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Loa Loa (eye worm) immunoglobulin I-set domain-containing protein 0.0092 0.3268 0.472
Brugia malayi SPRY domain containing protein 0.0071 0.1846 0.2667
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Schistosoma mansoni neuroglian 0.0116 0.4923 0.5739
Schistosoma mansoni cell adhesion molecule 0.0092 0.3268 0.381
Loa Loa (eye worm) CAMK protein kinase 0.0092 0.3268 0.472
Loa Loa (eye worm) CAMK/MLCK protein kinase 0.0116 0.4923 0.7111
Echinococcus granulosus receptor type tyrosine protein phosphatase zeta 0.0071 0.1846 0.1846
Schistosoma mansoni titin 0.0092 0.3268 0.381
Echinococcus granulosus Down syndrome cell adhesion molecule 0.0095 0.3502 0.3502
Echinococcus granulosus cell adhesion molecule 0.0071 0.1846 0.1846
Echinococcus multilocularis receptor type tyrosine protein phosphatase F 0.0116 0.4923 0.4923
Brugia malayi Protein-tyrosine phosphatase 0.0071 0.1846 0.2667
Schistosoma mansoni factor for adipocyte differentiation 0.0071 0.1846 0.2152
Loa Loa (eye worm) immunoglobulin I-set domain-containing protein 0.0092 0.3268 0.472
Schistosoma mansoni protein tyrosine phosphatase 0.0071 0.1846 0.2152
Schistosoma mansoni hypothetical protein 0.0071 0.1846 0.2152
Echinococcus granulosus anosmin 1 0.0071 0.1846 0.1846
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Echinococcus multilocularis roundabout 2 0.0116 0.4923 0.4923
Loa Loa (eye worm) UNCoordinated family member 0.0071 0.1846 0.2667
Echinococcus multilocularis Down syndrome cell adhesion molecule 0.0095 0.3502 0.3502
Trypanosoma cruzi Fibronectin type III domain containing protein, putative 0.0071 0.1846 0.5
Schistosoma mansoni defective proboscis extension response (dpr)-related 0.0073 0.2 0.2332
Brugia malayi Immunoglobulin I-set domain containing protein 0.0095 0.3502 0.5058
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Loa Loa (eye worm) fibronectin type III domain-containing protein 0.0071 0.1846 0.2667
Schistosoma mansoni tripartite motif protein trim9 0.0071 0.1846 0.2152
Onchocerca volvulus 0.0071 0.1846 0.565
Schistosoma mansoni hemicentin 0.0092 0.3268 0.381
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Schistosoma mansoni factor for adipocyte differentiation 0.0071 0.1846 0.2152
Schistosoma mansoni cell adhesion molecule 0.0092 0.3268 0.381
Echinococcus multilocularis receptor type tyrosine protein phosphatase zeta 0.0071 0.1846 0.1846
Schistosoma mansoni hypothetical protein 0.0071 0.1846 0.2152
Onchocerca volvulus 0.0092 0.3268 1
Schistosoma mansoni cell adhesion molecule 0.0116 0.4923 0.5739
Loa Loa (eye worm) hypothetical protein 0.0118 0.5077 0.7333
Onchocerca volvulus 0.0092 0.3268 1
Echinococcus multilocularis Immunoglobulin 0.0073 0.2 0.2
Schistosoma mansoni myosin-binding protein-related 0.0092 0.3268 0.381
Schistosoma mansoni receptor tyrosine phosphatase type r2a 0.0071 0.1846 0.2152
Brugia malayi protein-tyrosine phosphatase Lar-like precursor, putative 0.0071 0.1846 0.2667
Echinococcus granulosus Netrin receptor DCC 0.0071 0.1846 0.1846
Echinococcus granulosus roundabout 2 0.0116 0.4923 0.4923
Onchocerca volvulus 0.0071 0.1846 0.565
Schistosoma mansoni ephrin receptor 0.0092 0.3294 0.384
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Loa Loa (eye worm) hypothetical protein 0.0073 0.2 0.2889
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Schistosoma mansoni receptor protein tyrosine phosphatase 0.0071 0.1846 0.2152
Schistosoma mansoni nephrin 0.0116 0.4923 0.5739
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Schistosoma mansoni vesicular amine transporter 0.0073 0.2 0.2332
Brugia malayi Fibronectin type III domain containing protein 0.0145 0.6923 1
Echinococcus granulosus neuroglian 0.0094 0.3422 0.3422
Loa Loa (eye worm) hypothetical protein 0.0073 0.2 0.2889
Echinococcus multilocularis usherin 0.0071 0.1846 0.1846
Trypanosoma cruzi Fibronectin type III domain containing protein, putative 0.0071 0.1846 0.5
Loa Loa (eye worm) hypothetical protein 0.0097 0.3655 0.528
Brugia malayi Immunoglobulin I-set domain containing protein 0.0092 0.3268 0.472
Schistosoma mansoni titin 0.0092 0.3268 0.381
Echinococcus multilocularis cell adhesion molecule 0.0071 0.1846 0.1846
Onchocerca volvulus 0.0071 0.1846 0.565
Loa Loa (eye worm) projectin 0.0092 0.3268 0.472
Schistosoma mansoni nephrin 0.0165 0.8345 0.9728
Loa Loa (eye worm) hypothetical protein 0.0073 0.2 0.2889
Onchocerca volvulus 0.0071 0.1846 0.565
Loa Loa (eye worm) hypothetical protein 0.0116 0.4923 0.7111
Echinococcus multilocularis insulin growth factor 1 receptor beta 0.0092 0.3294 0.3294
Brugia malayi Immunoglobulin I-set domain containing protein 0.0118 0.5103 0.7371
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.0116 0.4923 0.4923
Onchocerca volvulus 0.0071 0.1846 0.565
Loa Loa (eye worm) hypothetical protein 0.0092 0.3268 0.472
Loa Loa (eye worm) hypothetical protein 0.0092 0.3268 0.472
Echinococcus multilocularis titin 0.0092 0.3268 0.3268
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Schistosoma mansoni factor for adipocyte differentiation 0.0071 0.1846 0.2152
Echinococcus multilocularis basement membrane specific heparan sulfate 0.0073 0.2 0.2
Brugia malayi protein unc-22 0.0092 0.3268 0.472
Brugia malayi myotactin form A 0.0071 0.1846 0.2667
Echinococcus granulosus Fibronectin type III domain containing protein 0.0071 0.1846 0.1846
Schistosoma mansoni tyrosine kinase 0.0065 0.1448 0.1687
Echinococcus multilocularis anosmin 1 0.0071 0.1846 0.1846
Onchocerca volvulus 0.0071 0.1846 0.565
Brugia malayi Fibronectin type III domain containing protein 0.0071 0.1846 0.2667
Onchocerca volvulus 0.0071 0.1846 0.565
Brugia malayi Lethal protein 805 0.0071 0.1846 0.2667
Echinococcus multilocularis roundabout 2 0.0116 0.4923 0.4923
Onchocerca volvulus 0.0071 0.1846 0.565
Echinococcus multilocularis Fibronectin, type III 0.0071 0.1846 0.1846
Brugia malayi Immunoglobulin I-set domain containing protein 0.0092 0.3268 0.472
Loa Loa (eye worm) fibronectin type III domain-containing protein 0.0071 0.1846 0.2667
Echinococcus multilocularis Receptor type tyrosine protein phosphatase O 0.0071 0.1846 0.1846
Echinococcus granulosus Fibronectin type III 0.0071 0.1846 0.1846
Brugia malayi Fibronectin type III domain containing protein 0.0071 0.1846 0.2667
Brugia malayi Immunoglobulin I-set domain containing protein 0.0116 0.4923 0.7111
Loa Loa (eye worm) fibronectin type III domain-containing protein 0.0071 0.1846 0.2667
Echinococcus granulosus titin 0.0092 0.3268 0.3268
Echinococcus granulosus insulin growth factor 1 receptor beta 0.0092 0.3294 0.3294
Brugia malayi Immunoglobulin I-set domain containing protein 0.0116 0.4923 0.7111
Brugia malayi Immunoglobulin I-set domain containing protein 0.0145 0.6923 1
Brugia malayi Immunoglobulin I-set domain containing protein 0.0092 0.3268 0.472
Echinococcus granulosus anosmin 1 0.0071 0.1846 0.1846
Schistosoma mansoni receptor tyrosine phosphatase type r2a 0.0116 0.4923 0.5739
Loa Loa (eye worm) CAMK/MLCK protein kinase 0.0092 0.3268 0.472
Echinococcus granulosus neurotracting:lsamp:neurotrimin:obcam 0.0097 0.3655 0.3655
Schistosoma mansoni hypothetical protein 0.0092 0.3268 0.381
Loa Loa (eye worm) hypothetical protein 0.0145 0.6923 1
Onchocerca volvulus 0.0071 0.1846 0.565
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Schistosoma mansoni Neurotrimin precursor (hNT) 0.0073 0.2 0.2332
Brugia malayi hypothetical protein 0.0071 0.1846 0.2667
Echinococcus granulosus usherin 0.0071 0.1846 0.1846
Echinococcus granulosus Phosphotidylinositol phosphatase PTPRQ 0.0071 0.1846 0.1846
Echinococcus granulosus roundabout 2 0.0116 0.4923 0.4923
Echinococcus multilocularis neuroglian 0.0116 0.4923 0.4923
Echinococcus multilocularis transfer RNA-Phe 0.0092 0.3268 0.3268
Echinococcus granulosus Netrin receptor DCC 0.0071 0.1846 0.1846
Schistosoma mansoni receptor tyrosine phosphatase type r2a 0.0071 0.1846 0.2152
Loa Loa (eye worm) fibronectin type III domain-containing protein 0.0071 0.1846 0.2667
Onchocerca volvulus 0.0071 0.1846 0.565
Echinococcus granulosus G1Y162 protein 0.0071 0.1846 0.1846
Echinococcus multilocularis fibronectin type III domain-containing protein 0.0071 0.1846 0.1846
Brugia malayi Twik (KCNK-like) family of potassium channels, alpha subunit 30. 0.0071 0.1846 0.2667
Schistosoma mansoni serine/threonine protein kinase 0.0092 0.3268 0.381
Brugia malayi Fibronectin type III domain containing protein 0.0071 0.1846 0.2667
Brugia malayi Immunoglobulin I-set domain containing protein 0.0092 0.3268 0.472
Echinococcus granulosus neuroglian 0.0116 0.4923 0.4923
Loa Loa (eye worm) hypothetical protein 0.0118 0.5077 0.7333
Loa Loa (eye worm) hypothetical protein 0.0071 0.1846 0.2667
Onchocerca volvulus 0.0092 0.3268 1
Echinococcus multilocularis neuroglian 0.0094 0.3422 0.3422
Schistosoma mansoni titin 0.0071 0.1846 0.2152
Echinococcus granulosus Immunoglobulin 0.0073 0.2 0.2
Echinococcus granulosus defective proboscis extension response 0.0073 0.2 0.2
Echinococcus multilocularis titin 0.0071 0.1846 0.1846
Loa Loa (eye worm) myotactin form A 0.0071 0.1846 0.2667
Onchocerca volvulus 0.0071 0.1846 0.565

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) = 49.9 % Antiasthamatic activity in ovalbumin-sensitized BALB/c mouse model assessed as inhibition of methacholine-induced airway hyperresponsiveness at 3 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge relative to control ChEMBL. 24900298
Activity (functional) = 67.4 % Antiasthamatic activity in ovalbumin-sensitized BALB/c mouse model assessed as inhibition of methacholine-induced airway hyperresponsiveness at 10 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge relative to control ChEMBL. 24900298
Activity (functional) = 73.6 % Antiasthamatic activity in ovalbumin-sensitized BALB/c mouse model assessed as inhibition of methacholine-induced airway hyperresponsiveness at 1 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge relative to control ChEMBL. 24900298
Cmax (ADMET) = 17.4 ug ml-1 Cmax in BALB/c mouse at 10 mg/kg, po ChEMBL. 24900298
IC50 (functional) = 120 nM Antagonist activity at human adenosine A2B receptor expressed in HEK293 cells assessed as inhibition of NECA-induced increase of intracellular cAMP level after 30 mins by ELISA ChEMBL. 24900298
IC50 (functional) = 512 nM Antagonist activity at mouse adenosine A2B receptor expressed in CHO cells assessed as inhibition of NECA-induced increase of intracellular cAMP level after 30 mins by ELISA ChEMBL. 24900298
IC50 (ADMET) = 5 uM Inhibition of CYP3A4 in human liver microsomes ChEMBL. 24900298
IC50 (ADMET) > 25 uM Inhibition of CYP1A2 in human liver microsomes ChEMBL. 24900298
IC50 (ADMET) > 25 uM Inhibition of CYP2C9 in human liver microsomes ChEMBL. 24900298
IC50 (ADMET) > 25 uM Inhibition of CYP2D6 in human liver microsomes ChEMBL. 24900298
Inhibition (functional) = 0 % Antiasthamatic activity in ovalbumin-sensitized airway hyperresponsiveness BALB/c mouse model assessed as inhibition of total IgG production at 10 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge ChEMBL. 24900298
Inhibition (functional) = 7 % Antiasthamatic activity in ovalbumin-sensitized airway hyperresponsiveness BALB/c mouse model assessed as inhibition of total IgE production at 10 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge ChEMBL. 24900298
Inhibition (functional) = 7 % Antiasthamatic activity in ovalbumin-sensitized airway hyperresponsiveness BALB/c mouse model assessed as inhibition of total IgG production at 1 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge ChEMBL. 24900298
Inhibition (functional) = 12 % Antiasthamatic activity in ovalbumin-sensitized airway hyperresponsiveness BALB/c mouse model assessed as inhibition of total IgE production at 3 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge ChEMBL. 24900298
Inhibition (functional) = 12 % Antiasthamatic activity in ovalbumin-sensitized airway hyperresponsiveness BALB/c mouse model assessed as inhibition of total IgG production at 3 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge ChEMBL. 24900298
Inhibition (binding) = 17 % Displacement of [3H]ZM241385 from human adenosine A2A receptor expressed in HeLa cells at 2.5 uM after 60 mins by scintillation proximity assay ChEMBL. 24900298
Inhibition (binding) = 17 % Binding affinity to human adenosine A2A receptor at 10 uM ChEMBL. 22148859
Inhibition (binding) = 38 % Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells at 10 uM after 3 hrs by filtration binding assay ChEMBL. 24900298
Inhibition (binding) = 38 % Binding affinity to human adenosine A3 receptor at 10 uM ChEMBL. 22148859
Inhibition (functional) = 41 % Antiasthamatic activity in ovalbumin-sensitized airway hyperresponsiveness BALB/c mouse model assessed as inhibition of total IgE production at 1 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge ChEMBL. 24900298
Inhibition (functional) = 42 % Antiasthamatic activity in ovalbumin-sensitized airway hyperresponsiveness BALB/c mouse model assessed as inhibition of IL-4 production in bronchoalveolar lavage fluid at 10 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge relative to control ChEMBL. 24900298
Inhibition (functional) = 44 % Antiasthamatic activity in ovalbumin-sensitized airway hyperresponsiveness BALB/c mouse model assessed as inhibition of IL-13 production in bronchoalveolar lavage fluid at 10 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge relative to control ChEMBL. 24900298
Inhibition (functional) = 50 % Antiasthamatic activity in ovalbumin-sensitized airway hyperresponsiveness BALB/c mouse model assessed as inhibition of IgE production at 3 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge ChEMBL. 24900298
Inhibition (binding) = 56 % Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells at 10 uM after 90 mins by filtration binding assay ChEMBL. 24900298
Inhibition (binding) = 56 % Binding affinity to human adenosine A1 receptor at 10 uM ChEMBL. 22148859
Inhibition (binding) = 61 % Displacement of [3H]ZM241385 from human adenosine A2A receptor expressed in HeLa cells at 25 uM after 60 mins by scintillation proximity assay ChEMBL. 24900298
Inhibition (functional) = 80 % Antiasthamatic activity in ovalbumin-sensitized airway hyperresponsiveness BALB/c mouse model assessed as inhibition of IgE production at 1 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge ChEMBL. 24900298
Inhibition (functional) = 81 % Antiasthamatic activity in ovalbumin-sensitized airway hyperresponsiveness BALB/c mouse model assessed as inhibition of IgE production at 10 mg/kg, po qd for 6 days administered 1 hr before ovalbumin challenge ChEMBL. 24900298
Ki (binding) = 24 nM Displacement of [3H]DPCPX from human adenosine A2B receptor expressed in HEK293 cells after 60 mins by filtration binding assay ChEMBL. 24900298
Ki (binding) = 24 nM Binding affinity to human adenosine A2B receptor at 10 uM ChEMBL. 22148859
Ki (ADMET) = 2.6 uM Inhibition of CYP2C19 in human liver microsomes ChEMBL. 24900298
Papp (ADMET) = 23 10'-6 cm/s Apparent permeability from basolateral to apical side in human Caco2 cells at 12.5 uM ChEMBL. 24900298
Papp (ADMET) = 37 10'-6 cm/s Apparent permeability from apical to basolateral side in human Caco2 cells at 12.5 uM ChEMBL. 24900298
PPB (ADMET) = 82 % Plasma protein binding in mouse by ultrafiltration assay ChEMBL. 24900298
PPB (ADMET) = 89 % Plasma protein binding in human by ultrafiltration assay ChEMBL. 24900298
Tmax (ADMET) = 0.25 hr Tmax in BALB/c mouse at 10 mg/kg, po ChEMBL. 24900298

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

2 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.